Efficacy and safety of immune checkpoint blockade in self‐identified Black patients with advanced non–small cell lung cancer-Reference-Cited by-同舟云学术

Efficacy and safety of immune checkpoint blockade in self‐identified Black patients with advanced non–small cell lung cancer

Published:2020-09-09 Issue:23 Volume:126 Page:5040-5049
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Nazha Bassel¹^ORCID,Goyal Subir²,Chen Zhengjia²³,Engelhart Anne¹,Carlisle Jennifer Wilkinson¹^ORCID,Beardslee Tyler J.¹,Gill Harpaul¹,Odikadze Levani⁴,Liu Yuan²³,Mishra Manoj K.⁵,Ramalingam Suresh S.¹^ORCID,Owonikoko Taofeek Kunle¹^ORCID

Affiliation:

1. Department of Hematology and Medical Oncology Winship Cancer Institute Emory University Atlanta Georgia

2. Bioinformatics and Systems Biology Shared Resource Winship Cancer Institute Emory University Atlanta Georgia

3. Department of Biostatistics and Bioinformatics Rollins School of Public Health Emory University Atlanta Georgia

4. Department of Medicine Emory University Atlanta Georgia

5. Cancer Biology Research and Training Program Department of Biological Sciences Alabama State University Montgomery Alabama

Funder

Emory University

National Cancer Institute

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33141

Reference29 articles.

1. The Tuskegee Legacy Project: Willingness of Minorities to Participate in Biomedical Research

2. Willingness of minorities to participate in biomedical studies: confirmatory findings from a follow‐up study using the Tuskegee Legacy Project Questionnaire [published correction appears in J Natl Med Assoc. 2007;99:1216];Katz RV;J Natl Med Assoc,2007

3. Are Racial and Ethnic Minorities Less Willing to Participate in Health Research?

4. Analysis of Racial/Ethnic Representation in Select Basic and Applied Cancer Research Studies

5. Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved?

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Immune Response within the Tumor Microenvironment in African American and Non-Hispanic White Patients with Non–Small Cell Lung Cancer;Cancer Epidemiology, Biomarkers & Prevention;2024-07-02

2. Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials;Cancers;2024-06-14

3. Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and Barriers;American Society of Clinical Oncology Educational Book;2024-06

4. CAR T-Cell Immunotherapy in Minority Patients with Lymphoma;NEJM Evidence;2024-03-26

5. Similar Efficacy Observed for First-Line Immunotherapy in Racial/Ethnic Minority Patients With Metastatic NSCLC;Journal of the National Comprehensive Cancer Network;2023-12